Cytek Biosciences, Inc.
CTKBFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Cytek Biosciences, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 6 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 16, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| D. E. Shaw & Co., Inc. | 2026-03-31 | 260,125 | $1.14M | SEC filing |
| AMERICAN CENTURY COMPANIES INC | 2026-03-31 | 281,681 | $1.23M | SEC filing |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2026-03-31 | 80,142 | Not shown | SEC filing |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 2026-03-31 | 6,362 | $27.8K | SEC filing |
| AE Wealth Management LLC | 2026-03-31 | 14,193 | $62K | SEC filing |
| ALLIANCEBERNSTEIN L.P. | 2026-03-31 | 141,048 | $712K | SEC filing |
| CAPTRUST FINANCIAL ADVISORS | 2026-03-31 | 16,434 | $71.8K | SEC filing |
| Everhart Financial Group, Inc. | 2026-03-31 | 12,962 | $56.6K | SEC filing |
| Versant Capital Management, Inc | 2026-03-31 | 2,735 | $12K | SEC filing |
| Squarepoint Ops LLC | 2026-03-31 | 25,296 | $111K | SEC filing |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 2026-03-31 | 582 | $2.54K | SEC filing |
| JPMORGAN CHASE & CO | 2026-03-31 | 299,090 | $1.29M | SEC filing |
| BANK OF AMERICA CORP /DE/ | 2026-03-31 | 1,009,054 | $4.41M | SEC filing |
| Maryland State Retirement & Pension System | 2026-03-31 | 15,656 | $68.4K | SEC filing |
| Parkside Financial Bank & Trust | 2026-03-31 | 66 | $289 | SEC filing |
| DEUTSCHE BANK AG\ | 2026-03-31 | 104,437 | $456K | SEC filing |
| Private Wealth Management Group, LLC | 2026-03-31 | 1,694 | $7.4K | SEC filing |
| FARMERS & MERCHANTS INVESTMENTS INC | 2026-03-31 | 60 | $262 | SEC filing |
| OREGON PUBLIC EMPLOYEES RETIREMENT FUND | 2026-03-31 | 25,175 | $110K | SEC filing |
| SIGNATUREFD, LLC | 2026-03-31 | 438 | $1.91K | SEC filing |
- Each value is checked against Cytek Biosciences, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 1 row: the filed value is about 1,000 times too small for the share count at Cytek Biosciences, Inc.'s share price.
120 filers have only one report here.
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-12 | Yan Ming · CHIEF TECHNOLOGY OFFICER | Common Stock | G — Bona fide gift | −135,892 | SEC filing |
| 2026-06-10 | Holder Michael · Director | Common Stock | M — Exercise or conversion of derivative security | +43,973 | SEC filing |
| 2026-06-10 | NEFF DEBORAH J · Director | Common Stock | M — Exercise or conversion of derivative security | +43,973 | SEC filing |
| 2026-06-10 | Holder Michael · Director | Restricted Stock Units | M — Exercise or conversion of derivative security | −43,973 | SEC filing |
| 2026-06-10 | Imper Vera · Director | Restricted Stock Units | M — Exercise or conversion of derivative security | −43,973 | SEC filing |
| 2026-06-10 | NEFF DEBORAH J · Director | Restricted Stock Units | M — Exercise or conversion of derivative security | −43,973 | SEC filing |
| 2026-06-10 | Ball Jack · Director | Restricted Stock Units | M — Exercise or conversion of derivative security | −43,973 | SEC filing |
| 2026-06-10 | Imper Vera · Director | Common Stock | M — Exercise or conversion of derivative security | +43,973 | SEC filing |
Showing 8 of 32 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.